Loading...
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial
IMPORTANCE: Post-hoc analyses from DRCR.net randomized trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results. OBJECTIVE: To provide additional post-hoc clinically relevant outcomes comparing three anti-VEGF agents f...
Na minha lista:
| Udgivet i: | JAMA Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567802/ https://ncbi.nlm.nih.gov/pubmed/27711918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2016.3698 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|